Advances in the Application of Human Umbilical Cord Mesenchymal Stem Cell in Liver Injury

Wei Zhou,Qifa Ye

DOI: https://doi.org/10.3877/cma.j.issn.1674-3903.2019.04.016

2019-01-01

Abstract:End-stage liver disease caused by various acute and chronic liver injuries is a serious threat to human health. Taking effective measures to delay or even reverse the progress of liver injury has become a medical problem urgently to be solved. Human umbilical cord mesenchymal stem cell (hucMSC) is widely used in the study of liver injury because of their pluripotency, low immunogenicity, and non-inducing tumorigenesis after continuous passage in vitro. The results of animal experiments showed that after the injection of hucMSC into the injured liver, liver oxidative stress, inflammatory response and liver necrosis were alleviated, and the degree of liver damage was also significantly reduced. In clinical studies of patients with liver injury, hucMSC can not only slow down the inflammatory response, but also improve the immune status of the patients and prolong their postoperative survival. This article reviews the research progress of hucMSC in treating liver injury and delaying the progress of liver cirrhosis in recent years. Key words: Human umbilical cord mesenchymal stem cell; Liver injury; Hepatic fibrosis